The Trump administration’s move to reschedule marijuana is popular, but most people support even broader cannabis reforms, according to a new federally funded study that examines public comments received during the government’s official consideration of the proposal.
The analysis of the 42,913 marijuana rescheduling comments submitted to the Drug Enforcement Administration (DEA) shows that 28.9 percent supported moving cannabis from Schedule I to Schedule III of the Controlled Substances Act (CSA) as proposed and that 63.5 percent wanted further rescheduling or even complete descheduling.
Only 6.7 percent of commenters opposed any reform and wanted to keep marijuana in Schedule I, the most restrictive CSA category that is supposed to be reserved for substances with no accepted medical use and a high potential for abuse.
The Department of Justice announced last week that marijuana products regulated by a state medical cannabis license immediately moved to Schedule III, as did any marijuana products that are approved by the Food and Drug Administration (FDA). An administrative hearing scheduled for his summer will consider broader cannabis rescheduling.
“Public sentiment on Regulations.gov supports the United States Drug Enforcement Administration’s proposal for cannabis rescheduling, though the majority views the proposed Schedule III classification as inadequate and
Read full article on Marijuana Moment
